ARTES Biotechnology
Elisabeth-Selbert-Str. 9
Langenfeld
40764
Germany
Tel: 49-0-2173-27587-0
Fax: 49-0-2173-27587-77
Website: http://www.artes-biotechnology.com/
16 articles about ARTES Biotechnology
-
ARTES Receives French Research Tax Credit (CIR) Accreditation
10/24/2017
The French R&D tax credit CIR gives French companies the ability to claim tax relief on 30% on all generated costs outsourced to ARTES' R&D services.
-
ARTES Biotechnology Received Next Grant Of Patent For METAVAX
8/10/2017
-
ARTES Biotechnology And BioSun Announce Co-Development For HPV Vaccine
11/4/2016
-
ARTES Biotechnology And Burnet Institute Join Forces To Develop Novel Hepatitis C Vaccine
7/26/2016
-
ARTES Biotechnology And Boehringer Ingelheim Animal Health Announce Collaboration
3/16/2015
-
ARTES Biotechnology, InstrAction And Q-Biologicals Join Forces For Veterinary Vaccine Development
10/6/2014
-
Malaria Transmission-blocking Vaccines – ARTES Biotechnology And Burnet Announced A Development Project
7/29/2014
-
ARTES Biotechnology Release: TA101 GOCLIN European Funded Project For The Development Of An Innovative Product For The Treatment Of Rheumatoid Arthritis – 1,7M€ Total Budget
12/23/2013
-
ARTES Biotechnology and Bio Farma Announce Collaboration in Vaccine Development
7/15/2013
-
ARTES Biotechnology and Midas Pharma GmbH Signed Cooperation Contract
6/24/2013
-
ARTES Biotechnology Issued New Patent in Australia for VLP Technology
4/22/2013
-
ARTES Biotechnology Announces a Strategic Collaboration Deal for Vaccine Development
4/24/2012
-
ARTES Biotechnology Steps Further into the Vaccine Business by Acquiring Anavax
9/27/2010
-
Q Chip Ltd And ARTES Biotechnology Announce Collaboration to Develop New Injectable Sustained Release Formulations of Therapeutic Proteins
4/30/2010
-
ARTES Biotechnology And Rhein Minapharm Biogenetics SAE Continue Their Successful Product Development Collaboration
11/17/2009
-
ARTES Biotechnology and m2p-labs Join Forces
2/26/2008